K-ro8

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameK-ro8

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsT lymphocytes modulators

TargetsUpdating

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSynimmune Gmbh

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSynimmune Gmbh

Active IndicationsN/A

Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A